TY - JOUR
T1 - Impact of sodium–glucose transport protein-2 (SGLT2) inhibitors on the inflammasome pathway in acute myocardial infarction in type 2 diabetes mellitus
T2 - a comprehensive review
AU - Yoo, Thomas T.
AU - Baek, In Hae
AU - Stoletniy, Liset
AU - Hilliard, Anthony
AU - Sakr, Antoine
AU - Doycheva, Desislava
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/5/26
Y1 - 2025/5/26
KW - Diabetes
KW - Inflammation
KW - Myocardial infarction
KW - Sodium–glucose transport protein-2 inhibitor
KW - Inflammation Mediators/metabolism
KW - NLR Family, Pyrin Domain-Containing 3 Protein/metabolism
KW - Humans
KW - Blood Glucose/metabolism
KW - Treatment Outcome
KW - Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
KW - Signal Transduction/drug effects
KW - Anti-Inflammatory Agents/therapeutic use
KW - Diabetes Mellitus, Type 2/drug therapy
KW - Myocardial Infarction/drug therapy
KW - Animals
KW - Inflammasomes/metabolism
KW - Sodium-Glucose Transporter 2/metabolism
KW - Biomarkers/blood
KW - Inflammation/drug therapy
UR - https://www.scopus.com/pages/publications/105006450257
UR - https://www.scopus.com/pages/publications/105006450257#tab=citedBy
UR - https://www.mendeley.com/catalogue/dfd17c2a-ec68-3b05-9d02-c986e14692a3/
U2 - 10.1186/s12933-025-02777-7
DO - 10.1186/s12933-025-02777-7
M3 - Review article
C2 - 40420176
AN - SCOPUS:105006450257
SN - 1475-2840
VL - 24
JO - Cardiovascular Diabetology
JF - Cardiovascular Diabetology
IS - 1
M1 - 227
ER -